An Additional Analysis of Data From the PARADIGM Exploratory Study (NCT02394834) in Patients With Advanced/Recurrent Colorectal Cancer

NCT05030493 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

787

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: mFOLFOX6 + panitumumab combination therapy
DRUG: mFOLFOX6 + bevacizumab combination therapy

Sponsor

Takeda